CHO-DHFR cell line development platform: Application of Clonepix and Automated Mini Bioreactor (AMBR) technologies to meet accelerated timelines

被引:0
|
作者
Venkata R Mangalampalli
Dyane Wycuff
Mingzhong Chen
David Berlinger
Elizabeth H Scheideman
Amritha Menon
Guilia Fabozzi
Althaf Hussain
Richard M Schwartz
机构
[1] NIAID,Vaccine Production Program, Vaccine Research Center
[2] National Institutes of Health,undefined
关键词
Semisolid Medium; Direct Cloning; Host Cell Line; Cell Line Generation; Cell Line Development;
D O I
10.1186/1753-6561-9-S9-P52
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 4 条
  • [1] Accelerated generation of high-yielding monoclonal stable CHO cell lines using a ClonePix-based cell line development platform
    Agarwal, Kitty
    Kachole, Mukta
    McKenzie, Angela
    Smedley, James
    Shukla, Abhinav
    Hussain, Althaf
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [2] Application of ambr250 mini-bioreactor platform to microcarrier cultures for high throughput vaccine development
    Malik, Wali
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [3] Investigation of Cell Line and Baculovirus Inocula Attributes for AAV Recombinant Vector Production in the ambr250 Automated Mini-Bioreactor System
    Yu, Darrick L.
    Therres, Jamy
    Machhi, Shushil
    Kurasawa, James
    Du, Jing
    Zhao, Xiaohui
    Chen, Zhongying
    Wang, Chunlei
    Sowers, Carrie
    Chen, Liyan
    Agarwal, Nitin
    MOLECULAR THERAPY, 2020, 28 (04) : 380 - 380
  • [4] Enhanced CHO Clone Screening: Application of Targeted Locus Amplification and Next-Generation Sequencing Technologies for Cell Line Development
    Aeschlimann, Samuel H.
    Graf, Christian
    Mayilo, Dmytro
    Lindecker, Helene
    Urda, Lorena
    Kappes, Nora
    Burr, Alicia Leone
    Simonis, Marieke
    Splinter, Erik
    van Min, Max
    Laux, Holger
    BIOTECHNOLOGY JOURNAL, 2019, 14 (07)